NL-OMON24041暂停不适用
International Second Immunoglobulin Dose in Guillain-Barré Syndrome patients with poor prognosis.<br>NO LONGER A SEPARATE STUDY. THIS STUDY WILL BELONG TO THE IGOS STUDY (NTR 3290).
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 300
研究概览
简要总结
The results of this I-SID GBS study will be submitted to an international journal.
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •To enter this GBS study:
- •1. Patients are diagnosed with GBS according to NINDS diagnostic criteria;
排除标准
- •To enter this GBS study:
- •1. Age less than 6 years;
研究者
相似试验
已完成
4 期
International Second Immunoglobulin Dose in Guillain-Barre Syndrome patients with poor prognosis.acute inflammatory demyelinating polyneuropathy (AIDP)Guillain-Barre syndrome1000381610034606NL-OMON35287Erasmus MC, Universitair Medisch Centrum Rotterdam15
已完成
不适用
International Guillain-Barré Syndrome Outcome StudyGuillain-Barré SyndromeMiller Fisher SyndromeNCT01582763Erasmus Medical Center2,000
招募中
不适用
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDPNL-OMON21678Amsterdam UMC, location AMC96
已完成
3 期
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseAlzheimer´s DiseaseNCT00818662Baxalta now part of Shire390
招募中
不适用
International GBS Outcome Study.Guillain-Barré syndromeNL-OMON22932Erasmus Medical Center1,000